Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000827871-16-000081
Filing Date
2016-11-23
Accepted
2016-11-23 16:00:54
Documents
1
Effectiveness Date
2016-11-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12741
  Complete submission text file 0000827871-16-000081.txt   13965
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-275107 | Film No.: 162016577
SIC: 2834 Pharmaceutical Preparations